Continuity of Care in the Resected Pancreatic Cancer Patient Population at Thomas Jefferson University Hospital

Authors

Christian Fernandez, MD, Thomas Jefferson UniversityFollow
Nazanin Sarpoulaki, Thomas Jefferson UniversityFollow
Andrew J. Song, MD, Thomas Jefferson UniversityFollow
Mark D. Hurwitz, MD, Thomas Jefferson UniversityFollow

Files

Description

Introduction

• Standard of care for resectable pancreatic cancer according to the National Comprehensive Cancer Network guidelines includes surgery, chemotherapy, and consideration of radiotherapy
• Thomas Jefferson University Hospital is a high volume institution with over 100 surgical pancreatic cancer cases per year
• Adjuvant treatment at high volume centers is recommended at all stages and inpatients at TJUH routinely receive inpatient radiation and medical oncology consultations prior to discharge to discuss the benefit of adjuvant therapies
• Despite these efforts and potential benefit to patients, the rate of follow up and delivery of adjuvant therapies at TJUH have not be characterized
• We retrospectively reviewed patients that received curative surgery at TJUH to assess follow up, adjuvant treatment, and evaluated associated variables

Publication Date

6-6-2019

City

Philadelphia

Keywords

quality improvement, pancreatic cancer, continuity of care, Thomas Jefferson University Hospital, patient care

Disciplines

Medicine and Health Sciences | Oncology | Radiation Medicine

Comments

Presented at the 2019 House Staff Quality Improvement and Patient Safety Conference

Recommended Citation

Fernandez, MD, Christian; Sarpoulaki, Nazanin; Song, MD, Andrew J.; and Hurwitz, MD, Mark D., "Continuity of Care in the Resected Pancreatic Cancer Patient Population at Thomas Jefferson University Hospital" (2019). House Staff Quality Improvement and Patient Safety Conference (2016-2019). Poster 135.
https://jdc.jefferson.edu/patientsafetyposters/135